Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
TrueBlue Inc (NYSE: TBI) closed the day trading at $6.33 down -15.03% from the previous closing price of $7.45. In other words, the price has decreased by -$15.03 from its previous closing price. On the day, 0.5 million shares were traded.
Ratios:
For a better understanding of TBI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on May 22, 2023, Upgraded its rating to Outperform and sets its target price to $20 from $18 previously.
On May 26, 2022, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $36 to $20.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.11 while its Price-to-Book (P/B) ratio in mrq is 0.57.
Stock Price History:
Over the past 52 weeks, TBI has reached a high of $12.88, while it has fallen to a 52-week low of $6.63. The 50-Day Moving Average of the stock is -20.28%, while the 200-Day Moving Average is calculated to be -27.30%.
Shares Statistics:
A total of 29.50M shares are outstanding, with a floating share count of 28.28M. Insiders hold about 4.33% of the company’s shares, while institutions hold 96.82% stake in the company.
